Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer (Q40800385)
scientific article
Language:
Current Data About Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer
(P31) (Q13442814)
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P304) 319-323
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P478) 17
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P577) Friday, January 1, 1999
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P921) (Q412197)
(P887)

(Q412415)
(P887)

(P1433) (Q400292)
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P1476) "Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer" (language: en)
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

(P2093) N Boku
(P1545) 1
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

A Ohtsu
(P1545) 2
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

Y Shimada
(P1545) 3
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

K Shirao
(P1545) 4
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

S Seki
(P1545) 5
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

H Saito
(P1545) 6
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

Y Sakata
(P1545) 7
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

I Hyodo
(P1545) 8
(P248)
(P698) 10458249
(P813) Saturday, September 23, 2017

other details
description scientific article

External Links
(P356) 10.1200/JCO.1999.17.1.319
(P698) 10458249